ArticleiScience2025
A calcium-sensing receptor dileucine motif directs internalization to spatially distinct endosomal signaling pathways.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MRAP2 potentiates GPCR signaling by conserved mechanisms that are disrupted by obesity-associated genetic variants.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
G protein-coupled receptors (GPCRs) can temporally alter signaling by generating secondary signals from internalized receptors. However, the motifs required to direct GPCRs to these pathways are ill defined. The GPCR, calcium-sensing receptor (CaSR), regulates parathyroid hormone release by promiscuous G protein coupling at cell surfaces and by selectively recruiting Gq/11 to early endosomal membranes. Here, we demonstrate that a dileucine endocytic motif is required for directing CaSR to dynamic spatiotemporal pathways by interacting with the adaptor protein-2 σ-subunit, which is mutated in hypercalcemic patients. From early endosomes, internalized CaSR is targeted to spatially distinct pathways involving early-to-recycling and late endosomes, to direct compartment-specific signals and regulate GPCR forward trafficking. The clinically available allosteric modulator cinacalcet biases signaling to preferentially enhance early endosomal-to-recycling pathways, demonstrating the veracity of targeting discrete endosomal pathways. These results reveal that single GPCRs can simultaneously activate spatially distinct endosomal pathways and demonstrate the structural motifs that facilitate such multidimensional signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.